Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

Glenn, Andrea J.; Hernández‐Alonso, Pablo; Kendall, Cyril W.C.; Martínez‐González, Miguel Ángel; Corella, Dolores; Fitó, Montserrat; Martínéz, J. Alfredo; Alonso‐Gómez, Ángel M.; Wärnberǵ, Julia; Vioque, Jesús; Romaguera, Dora; López‐Miranda, José; Estruch, Ramón; Tinahones, Francisco J.; Lapetra, José; Serra‐Majem, J. Luís; Bueno‐Cavanillas, Aurora; Tur, Josep A.; Celada, Sofía Reguero; Pintó, Xavier; Delgado-Rodrı́guez, Miguel; Matía‐Martín, Pilar; Vidal, Josep; Mas, Sebastián; Daimiel, Lidia; Ros, Emilio; Jenkins, David; Toledo, Estefanía; Sorlí, José V.; Castañer, Olga; Abete, Itziar; Rodríguez, Anai Moreno; Fernández-Barceló, Olga; Oncina-Cánovas, Alejandro; Konieczna, Jadwiga; García‐Rios, Antonio; Casas, Rosa; Gómez-Pérez, Ana María; Santos‐Lozano, José Manuel; Vázquez‐Ruiz, Zenaida; Portolés, Olga; Schröder, Helmut; Zulet, M. Ángeles; Eguaras, Sonia; Lete, Itziar Salaverria; Zomeño, María Dolores; Sievenpiper, John L.; Salas‐Salvadó, Jordi

doi:10.1016/j.clnu.2021.03.016

Cited by 26 publications

(18 citation statements)

References 61 publications

(45 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No que diz respeito à composição corporal, no início do estudo foi possível observar a prevalência de participantes obesos e com perímetros (braço, cintura e quadril) aumentados. Estima-se que 20 a 30% da prevalência de HAS associa-se com o excesso de peso, e com alguns fatores de risco, como tabagismo, ingestão de bebidas alcoólicas, sedentarismo, para o desenvolvimento dessa enfermidade (Glenn et al, 2021;Nascimento et al, 2021).…”

Section: Discussionunclassified

Avaliação da eficácia da dieta DASH em pacientes hipertensos

Souza

Faria

Vidigal

2022

RSD

View full text Add to dashboard Cite

Objetivos: Avaliar a eficácia da dieta DASH em pacientes hipertensos em um município do sul de Minas Gerais, Brasil. Metodologia: Estudo longitudinal prospectivo, realizado com 13 pacientes hipertensos, idade média de 62,5 ± 10,5 anos, recrutados de uma Clínica de Fisioterapia da cidade Alfenas, Minas Gerais. Foram realizados atendimentos individuais e em grupo. As consultas individuais ocorreram no tempo 0 (baseline), 7º dia e 37º após a primeira consulta. Já as atividades em grupo aconteceram no 15º e 30º dia após a primeira consulta. Os desfechos foram: mudanças no estado nutricional (avaliação antropométrica e da composição corporal), no padrão alimentar (score total da dieta DASH) e na PA. Resultados e Discussão: Não houve diferenças estatísticas nos desfechos estado nutricional, padrão alimentar e PA (p > 0,05). No entanto, os pacientes perderam em média 1,01 ± 2,3 kg de peso após o 37º dia de intervenção (p = 0,07). Observou-se alta adesão da intervenção, por meio da dieta DASH, em 61,5% pacientes (n=6). Conclusões: Mesmo com um pequeno tempo de intervenção (30 dias) foram observados resultados positivos quanto ao padrão dietético de alguns dos componentes da dieta DASH e uma tendência à redução no peso corporal.

show abstract

Section: Discussionunclassified

Avaliação da eficácia da dieta DASH em pacientes hipertensos

Souza

Faria

Vidigal

2022

RSD

View full text Add to dashboard Cite

show abstract

“…To date, we have assessed our PDS in an overweight/obese population with metabolic syndrome in the PREDIMED-Plus clinical trial cohort and with incident CVD outcomes in postmenopausal women in the Women’s Health Initiative (WHI). Greater adherence to our PDS was significantly associated with lower HbA1c, fasting plasma glucose, triglycerides, BMI and waist circumference over one year in PREDIMED-Plus [ 17 ], and was significantly associated with a lower risk of CVD, coronary heart disease and heart failure in the WHI [ 18 ]. These two studies provide further evidence that the PDS can predict improvements in several cardiometabolic risk factors and diseases.…”

Section: Discussionmentioning

confidence: 99%

“…A priori dietary patterns that are based upon nutrition knowledge of a diet shown to be healthful, such as the Portfolio Diet, are typically assessed with disease outcomes in prospective cohorts through the creation of a diet index or score. However, adherence to the Portfolio Diet has not been assessed in these study designs, aside from two recent studies by our group [ 17 , 18 ], and a diet index/scoring system for this diet has not been formally described or evaluated in terms of its validity. A Portfolio Diet score (PDS) will be particularly useful applied to food frequency questionnaires (FFQs), as they are the most common diet assessment tools used in population-based observational studies [ 19 ], including prospective cohort studies.…”

Section: Introductionmentioning

confidence: 99%

Development of a Portfolio Diet Score and Its Concurrent and Predictive Validity Assessed by a Food Frequency Questionnaire

et al. 2021

View full text Add to dashboard Cite

The Portfolio Diet, a plant-based portfolio of cholesterol-lowering foods, has been shown to reduce low-density lipoprotein cholesterol (LDL-C), and other cardiovascular risk factors, in randomized controlled trials (RCTs). It is not known if these beneficial effects translate to a lower incidence cardiovascular disease (CVD) risk. To support examinations between Portfolio Diet adherence and disease, a Portfolio Diet score (PDS) was developed and its predictive and concurrent validity was assessed within the Toronto Healthy Diet Study, a six-month RCT in overweight adults. Predictive validity was assessed using change in the PDS measured by food frequency questionnaire (FFQ) and concomitant change in LDL-C from baseline to six months using multiple linear regression, adjusted for potential confounders (n = 652). Concurrent validity was assessed in a subset of participants (n = 50) who completed the FFQ and a 7-day diet record (7DDR) at baseline. The PDS determined from each diet assessment method was used to derive correlation coefficients and Bland–Altman plots to assess the between-method agreement. The change in PDS was inversely associated with change in LDL-C (β coefficients: −0.01 mmol/L (95% confidence intervals (CIs): −0.02, −0.002; p = 0.02). The correlation between the PDS from the FFQ and 7DDR was 0.69 (95% CIs: 0.48, 0.85). The Bland–Altman plot showed reasonable agreement between the score from the FFQ and 7DDR. These findings indicate predictive validity of the PDS with lower LDL-C, and reasonable concurrent validity of the PDS as assessed by an FFQ against a 7DDR.

show abstract

“…Although the present study has not demonstrated the long-term benefit of the Portfolio Diet in reducing mortality risk due to CVD, further recent analyses revealed the prospective benefit of the adherence to the Portfolio Diet on cardiometabolic health. Higher adherence to the PDS was associated with lower LDL-C in the Toronto Healthy Diet Study [8], as well as with improvements in cardiometabolic risk factors, including glycated hemoglobin, fasting plasma glucose, triglycerides, waist circumference and BMI, in the PREDIMED-Plus cohort [9].…”

Section: Comparison With Previous Literaturementioning

confidence: 92%

“…In addition to clinical trials for patients with dyslipidemia, the health benefits of the Portfolio Diet were also examined among cohort studies. A Portfolio Diet score (PDS) has been developed and validated to assess the adherence to the Portfolio Diet using food frequency questionnaires (FFQ) [8], and to date, the PDS has been associated with lower cardiometabolic risk factors in the Prevención con Dieta Mediterránea (PREDIMED)-Plus cohort and lower risk of CVD in the Women's Health Initiative (WHI) [9,10].…”

Section: Introductionmentioning

confidence: 99%

Prospective Association of the Portfolio Diet with All-Cause and Cause-Specific Mortality Risk in the Mr. OS and Ms. OS Study

Glenn

Yeung

et al. 2021

Nutrients

Self Cite

View full text Add to dashboard Cite

The Portfolio Diet has demonstrated its cardiovascular benefit from interventions, but the association between Portfolio Diet adherence and the risk of all-cause and cause-specific mortality has not been examined in Chinese population. The present study has collected Portfolio Diet adherence (assessed by food frequency questionnaire), lifestyle factors and mortality status of 3991 participants in the Mr. Osteoporosis (OS) and Ms. OS Study. Cox regression models were used to examine the association between the Portfolio Diet adherence and mortality risk (all-cause, cardiovascular disease or cancer). The highest quartile of the Portfolio Diet score was associated with a 28% lower risk of all-cause (hazard ratio, HR: 0.72) and cancer (HR: 0.72) mortality, respectively. The association between Portfolio Diet adherence and cardiovascular disease mortality did not reach statistical significance (HR: 0.90, 95% CI = 0.64, 1.26). Among male participants, the highest adherence to the Portfolio Diet was also associated with a lower risk of all-cause (HR: 0.63) and cancer mortality (HR: 0.59), and there was an inverse association between food sources of plant protein and the risk of cardiovascular mortality (HR: 0.50). However, most associations between the Portfolio Diet and mortality were not significant among females. The protection for cancer mortality risk might reach the plateau at the highest adherence to the Portfolio Diet for females. To conclude, greater adherence to the Portfolio Diet was significantly associated with a lower risk of mortality in Hong Kong older adults, and the associations appeared stronger among males.

show abstract

Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

Cited by 26 publications

References 61 publications

Avaliação da eficácia da dieta DASH em pacientes hipertensos

Avaliação da eficácia da dieta DASH em pacientes hipertensos

Development of a Portfolio Diet Score and Its Concurrent and Predictive Validity Assessed by a Food Frequency Questionnaire

Prospective Association of the Portfolio Diet with All-Cause and Cause-Specific Mortality Risk in the Mr. OS and Ms. OS Study

Contact Info

Product

Resources

About